| Variant (CDS) | Variant (protein) | Variant Type | Variant Effect | Genomic Location (GRCh37) | ExAC Frequency |
| c.1805-9_1805-8insT | insertion | splice site | chr6:123581791-123581792 (reverse strand) | 0.43349389 |
As this variant is present at a population frequency of 0.43349389 (ExAC mean allelic frequency), it is highly unlikely to be pathogenic.
| Database | European | African | East Asian | South Asian | American | Finnish | Other | Total |
|---|---|---|---|---|---|---|---|---|
| ExAC | 0.43486352 2804 / 6448 | 0.45156695 634 / 1404 | 0.48122066 205 / 426 | 0.43051014 2633 / 6116 | 0.46296296 125 / 270 | 0.39836795 537 / 1348 | 0.45054945 82 / 182 | 0.43349389 7020 / 16194 |
| ESP | 0.00000 0 / 8600 |
0.00000 0 / 4400 |
0.00000 0 / 13000 |
|||||
| 1KG |
0.00000 0 / 1006 |
0.00000 0 / 1322 |
0.00000 0 / 1008 |
0.00000 0 / 978 |
0.00000 0 / 694 |
0.00000 0 / 198 |
0.00000 0 / 5008 |
The Exome Aggregation Consortium (ExAC) is a database of 60,706 unrelated individuals sequenced as part of various disease-specific and population genetic studies. There is partial overlap between ExAC and 1000 Genomes (1KG) (1,851 of the 2,504 samples in 1KG) and the Exome Sequencing Project (ESP) (3,936 of the 6,500 samples in ESP).
| Canonical Sequences | ![]() |
![]() |
![]() |
![]() |
|---|---|---|---|---|
| Transcript | ENST00000398178 | NM_006073.2 | ||
| Protein | ENSP00000381240 | Q13061 |
1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.
2. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014 Aug;16(8):601-8.
3. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL.
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.
Genet Med. 2015 Nov;17(11):880-8.